Here are the editors' top picks for the week ended March 23.
Once questioned as science fiction, more surgeons becoming open to using robots
While a debate continues over the use of robots in hip and knee surgeries, proponents see signs that surgeons are increasingly accepting the technology.
Drugmakers target new approaches in drive to treat schizophrenia
There have been remarkably few advances in the treatments available for those diagnosed with schizophrenia in recent decades, but Cardiff University researchers have uncovered 50 new genes and brain pathways that increase the risk of developing it.
Sanofi, Regeneron, J&J drugs featured at US cardiology meeting
Regeneron Pharmaceuticals Inc. and Sanofi's cholesterol-lowering drug Praluent took center stage at the American College of Cardiology annual meeting in Orlando, Fla.
Trump says to expect 'beautiful' plan targeting high drug prices next month
President Donald Trump said he plans to roll out a detailed plan next month to lower U.S. drug prices.
Biomedical research, opioid crisis to get billions under 'omnibus' spending bill
House and Senate leaders have agreed to give the National Institutes of Health a $3 billion funding boost under the $1.3 trillion omnibus spending package unveiled late March 21.
House right-to-try experimental drugs bill succeeds on 2nd attempt
A bill to give critically ill patients greater access to experimental drugs beyond the U.S. Food and Drug Administration's current compassionate-use process succeeded in the House on the legislation's second attempt.
Capitol Checkup: CDC top job contender; 'gag' ban bills; force of nature lost
HIV/AIDS expert Robert Redfield is the top contender to lead the Centers for Disease Control and Prevention; two bills were introduced aimed at banning so-called gag clause practices, and a force of nature was lost on Capitol Hill.
Trump turns to 'toughness,' fear tactics to fight opioid crisis
The U.S. president said he plans to take "tough" measures to fight the epidemic, like seeking the death penalty for traffickers, building a wall to keep illicit substances out of the U.S. and launching ads to scare youngsters from trying the drugs.